These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 11698930)

  • 21. COX-2 inhibitor use after Vioxx: careful balance or end of the rope?
    Fendrick AM
    Am J Manag Care; 2004 Nov; 10(11 Pt 1):740-1. PubMed ID: 15623263
    [No Abstract]   [Full Text] [Related]  

  • 22. Vioxx withdrawal alarms cancer prevention researchers.
    Vanchieri C
    J Natl Cancer Inst; 2004 Dec; 96(23):1734-5. PubMed ID: 15572751
    [No Abstract]   [Full Text] [Related]  

  • 23. GI events leading to death in association with celecoxib and rofecoxib.
    Weaver J; Bonnel RA; Karwoski CB; Brinker AD; Beitz J
    Am J Gastroenterol; 2001 Dec; 96(12):3449-50. PubMed ID: 11774975
    [No Abstract]   [Full Text] [Related]  

  • 24. Painful lessons.
    Nat Struct Mol Biol; 2005 Mar; 12(3):205. PubMed ID: 15744317
    [No Abstract]   [Full Text] [Related]  

  • 25. Cyclooxygenase-2 inhibitors and cardiovascular risk.
    Smith ER
    Can J Cardiol; 2005 Mar; 21(3):307-8. PubMed ID: 15776124
    [No Abstract]   [Full Text] [Related]  

  • 26. Cyclooxygenase inhibition and adverse remodeling during healing after myocardial infarction.
    Jugdutt BI
    Circulation; 2007 Jan; 115(3):288-91. PubMed ID: 17242292
    [No Abstract]   [Full Text] [Related]  

  • 27. Differences between COX-2-specific inhibitors: clinical and economic implications.
    Sonnenblick EH
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S428-30. PubMed ID: 12416792
    [No Abstract]   [Full Text] [Related]  

  • 28. Summaries for patients. Cyclooxygenase-2 inhibitors and heart attacks: varying effects?
    Ann Intern Med; 2005 Feb; 142(3):I21. PubMed ID: 15684199
    [No Abstract]   [Full Text] [Related]  

  • 29. FDA advisers warn: COX 2 inhibitors increase risk of heart attack and stroke.
    Lenzer J
    BMJ; 2005 Feb; 330(7489):440. PubMed ID: 15731142
    [No Abstract]   [Full Text] [Related]  

  • 30. Cardiovascular safety of COX-2 inhibitors.
    Med Lett Drugs Ther; 2001 Nov; 43(1118):99-100. PubMed ID: 11707751
    [No Abstract]   [Full Text] [Related]  

  • 31. Failing the public health--rofecoxib, Merck, and the FDA.
    Topol EJ
    N Engl J Med; 2004 Oct; 351(17):1707-9. PubMed ID: 15470193
    [No Abstract]   [Full Text] [Related]  

  • 32. Coxib medications to be handled with care.
    Misak A
    CMAJ; 2005 Feb; 172(3):330. PubMed ID: 15615922
    [No Abstract]   [Full Text] [Related]  

  • 33. [Safety of selective inhibitors of inducible cyclooxygenase-2 taken for a long period].
    Lamarque D
    Bull Cancer; 2004 May; 91 Spec No():S117-24. PubMed ID: 15239340
    [TBL] [Abstract][Full Text] [Related]  

  • 34. COX-2 inhibitors: no pain, no heart gain?
    Harv Heart Lett; 2001 Dec; 12(4):2-4. PubMed ID: 11751079
    [No Abstract]   [Full Text] [Related]  

  • 35. Cutaneous vasculitis induced by cyclo-oxygenase-2 selective inhibitors.
    Drago F; Brusati C; Desirello G; Cacciapuoti M; Rebora A
    J Am Acad Dermatol; 2004 Dec; 51(6):1029-30. PubMed ID: 15583611
    [No Abstract]   [Full Text] [Related]  

  • 36. [COX-2 inhibitors--one step forward and two steps back].
    Evensen S; Spigset O; Slørdal L
    Tidsskr Nor Laegeforen; 2005 Apr; 125(7):875-8. PubMed ID: 15815733
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials. Halt of Celebrex study threatens drug's future, other trials.
    Couzin J
    Science; 2004 Dec; 306(5705):2170. PubMed ID: 15618492
    [No Abstract]   [Full Text] [Related]  

  • 38. Could Bextra increase heart risks too?
    Health News; 2004 Dec; 10(12):2. PubMed ID: 15645556
    [No Abstract]   [Full Text] [Related]  

  • 39. Urticaria and angioedema from cyclooxygenase-2 inhibitors.
    Kelkar PS; Butterfield JH; Teaford HG
    J Rheumatol; 2001 Nov; 28(11):2553-4. PubMed ID: 11708434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective.
    Hochberg MC
    Am J Manag Care; 2002 Nov; 8(17 Suppl):S502-17. PubMed ID: 12458820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.